Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. ACN
4. IONS
5. AZN
6. ROIV
7. AAPL
8. QCOM
9. NVDA
10. USO

Go back to Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

Iovance Biotherapeutics (IOVA) Misses Q1 EPS by 1c

May 7, 2019 4:50 PM EDT

Iovance Biotherapeutics (NASDAQ: IOVA) reported Q1 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29).

We have made great progress in recent months in advancing TIL therapy toward commercialization. In April, we dosed the first patient in the pivotal study, Cohort 4 of the... More